A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
Conditions: Shingles; Herpes Zoster Infection; Human Interventions: Biological: Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection; Biological: Candidate 1: PF-07915234: VZV modRNA Suspension for Injection; Biological: Candidate 2: PF-07921188: VZV modRNA Suspension for Injection; Biological: Candidate 3: PF-07921186: VZV modRNA Su spension for Injection; Biological: Shingrix; Biological: Selected Vaccine Candidate group (Dose level, Schedule); Biological: Shingrix - SSB Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Learning | Pfizer | Research | Shingles | Shingles (Herpes Zoster) Vaccine | Study | Universities & Medical Training | Vaccines